These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15722396)
1. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175). Miller K; Storey C; Stubbings WJ; Hoyle AM; Hobbs JK; Chopra I J Antimicrob Chemother; 2005 Apr; 55(4):579-82. PubMed ID: 15722396 [TBL] [Abstract][Full Text] [Related]
2. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae. Moisan H; Pruneau M; Malouin F J Antimicrob Chemother; 2010 Apr; 65(4):713-6. PubMed ID: 20097788 [TBL] [Abstract][Full Text] [Related]
3. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus. Fasola EL; Fasching CE; Peterson LR J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci. Huang V; Brown WJ; Rybak MJ Antimicrob Agents Chemother; 2004 Jul; 48(7):2719-23. PubMed ID: 15215134 [TBL] [Abstract][Full Text] [Related]
5. A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA). Murphy JT; Walshe R; Devocelle M J Theor Biol; 2008 Sep; 254(2):284-93. PubMed ID: 18577389 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
8. [Mechanism of beta-lactam-resistance in methicillin-resistant Staphylococcus aureus]. Okonogi K Rinsho Byori; 1990 Sep; 38(9):983-9. PubMed ID: 2232271 [TBL] [Abstract][Full Text] [Related]
9. Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall. Fuda C; Hesek D; Lee M; Morio K; Nowak T; Mobashery S J Am Chem Soc; 2005 Feb; 127(7):2056-7. PubMed ID: 15713078 [TBL] [Abstract][Full Text] [Related]
10. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Moreillon P Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():32-41. PubMed ID: 18318877 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus. Park YS; Shin WS; Kim SK J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852 [TBL] [Abstract][Full Text] [Related]
12. Evolution and resistance expression of MRSA. Evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression. Asada K; Inaba Y; Tateda-Suzuki E; Kuwahara-Arai K; Ito T; Hiramatsu K Acta Biochim Pol; 1995; 42(4):517-24. PubMed ID: 8852342 [TBL] [Abstract][Full Text] [Related]
13. LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus. Vouillamoz J; Entenza JM; Hohl P; Moreillon P Antimicrob Agents Chemother; 2004 Nov; 48(11):4322-7. PubMed ID: 15504859 [TBL] [Abstract][Full Text] [Related]
14. Salvipisone and aethiopinone from Salvia sclarea hairy roots modulate staphylococcal antibiotic resistance and express anti-biofilm activity. Walencka E; Rozalska S; Wysokinska H; Rozalski M; Kuzma L; Rozalska B Planta Med; 2007 Jun; 73(6):545-51. PubMed ID: 17650545 [TBL] [Abstract][Full Text] [Related]
15. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases. Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674 [TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED. Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609 [TBL] [Abstract][Full Text] [Related]
18. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus. Yokota T; Yoshida R; Utsui Y; Tajima M Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273 [TBL] [Abstract][Full Text] [Related]
19. Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant Staphylococcus aureus. Aqil F; Khan MS; Owais M; Ahmad I J Basic Microbiol; 2005; 45(2):106-14. PubMed ID: 15812867 [TBL] [Abstract][Full Text] [Related]
20. Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Lim D; Strynadka NC Nat Struct Biol; 2002 Nov; 9(11):870-6. PubMed ID: 12389036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]